| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |